Search by Drug Name or NDC
NDC 68462-0436-10 Olmesartan Medoxomil 5 mg/1 Details
Olmesartan Medoxomil 5 mg/1
Olmesartan Medoxomil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is OLMESARTAN MEDOXOMIL.
MedlinePlus Drug Summary
Olmesartan is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years of age and older. Olmesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 68462-0436-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Olmesartan
Product Information
| NDC | 68462-0436 |
|---|---|
| Product ID | 68462-436_aa9a7b83-61b7-40c9-9fa0-4d627324b7bc |
| Associated GPIs | 36150055200320 |
| GCN Sequence Number | 050288 |
| GCN Sequence Number Description | olmesartan medoxomil TABLET 5 MG ORAL |
| HIC3 | A4F |
| HIC3 Description | ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST |
| GCN | 17284 |
| HICL Sequence Number | 023490 |
| HICL Sequence Number Description | OLMESARTAN MEDOXOMIL |
| Brand/Generic | Generic |
| Proprietary Name | Olmesartan Medoxomil |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Olmesartan Medoxomil |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | OLMESARTAN MEDOXOMIL |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203281 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68462-0436-10 (68462043610)
| NDC Package Code | 68462-436-10 |
|---|---|
| Billing NDC | 68462043610 |
| Package | 1000 TABLET, FILM COATED in 1 BOTTLE (68462-436-10) |
| Marketing Start Date | 2017-05-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |